Recent Trends in Antifungal Agents and Antifungal Therapy

Fungal infections have taken a new spectrum due to the increased incidence of multi-drug resistant fungal pathogens. Freedom of choice for drugs to treat fungal infections is also narrow because of lesser probability of discovering drugs that would bypass affecting human cells and target fungal cell...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Basak, Amit (Επιμελητής έκδοσης), Chakraborty, Ranadhir (Επιμελητής έκδοσης), Mandal, Santi M. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: New Delhi : Springer India : Imprint: Springer, 2016.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03551nam a22005295i 4500
001 978-81-322-2782-3
003 DE-He213
005 20160921133546.0
007 cr nn 008mamaa
008 160921s2016 ii | s |||| 0|eng d
020 |a 9788132227823  |9 978-81-322-2782-3 
024 7 |a 10.1007/978-81-322-2782-3  |2 doi 
040 |d GrThAP 
050 4 |a QK600-638 
072 7 |a PSQ  |2 bicssc 
072 7 |a PSAK  |2 bicssc 
072 7 |a SCI086000  |2 bisacsh 
072 7 |a SCI029000  |2 bisacsh 
082 0 4 |a 579.135  |2 23 
245 1 0 |a Recent Trends in Antifungal Agents and Antifungal Therapy  |h [electronic resource] /  |c edited by Amit Basak, Ranadhir Chakraborty, Santi M. Mandal. 
264 1 |a New Delhi :  |b Springer India :  |b Imprint: Springer,  |c 2016. 
300 |a IX, 250 p. 119 illus., 10 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a 1. Fungi Fights Fungi: Tip off in Antifungal Chemotherapy -- 2. Essential Oil and Antifungal Therapy -- 3. Antifungal Peptides with Potential Against Pathogenic Fungi -- 4. Lipopeptides: Status and Strategies to Control Fungal Infection -- 5. Plant Derived Antifungal Agents: Past and Recent Developments -- 6. Recent Advancements in Combinational Antifungal Therapy and Immunotherapy -- 7. Nanocarriers of Antifungal Agents -- 8. Synthetic Compounds for Antifungal Chemotherapy -- 9. Antifungal therapy in Eye infections: New Drugs, New Trends -- 10. Antifungal Susceptibility Testing of Dermatophytes. 
520 |a Fungal infections have taken a new spectrum due to the increased incidence of multi-drug resistant fungal pathogens. Freedom of choice for drugs to treat fungal infections is also narrow because of lesser probability of discovering drugs that would bypass affecting human cells and target fungal cells producing fewer side effects in patients. An approach has gained prominence in research is to look for bioactive antifungal compounds from natural to synthetic sources. It is necessary to discover new classes of antifungals to control the recent emergence of multi-drug resistant fungal infections. This book proposed a details top to bottom outline of antifungal compounds derived naturally or synthetically. The details of their modifications or synthetic analogues have been described, helpful to understand the structure-activity relationship which leads to new compound development in antifungal chemotherapy. Each chapter begins with a comprehensive, top-bottom in-depth discussion of antifungal agents with updated bibliographic references. This compendium will serve as a companion not only for Scientists, Researchers, and Professors, Medical Practitioners but also a valuable reference text for the university students. . 
650 0 |a Life sciences. 
650 0 |a Immunology. 
650 0 |a Bacteriology. 
650 0 |a Microscopy. 
650 0 |a Mycology. 
650 1 4 |a Life Sciences. 
650 2 4 |a Mycology. 
650 2 4 |a Bacteriology. 
650 2 4 |a Biological Microscopy. 
650 2 4 |a Immunology. 
700 1 |a Basak, Amit.  |e editor. 
700 1 |a Chakraborty, Ranadhir.  |e editor. 
700 1 |a Mandal, Santi M.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9788132227809 
856 4 0 |u http://dx.doi.org/10.1007/978-81-322-2782-3  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)